Topic: Alzheimer.
Destination: The Drug Development RFP supports investigational new drug (IND)-enabling studies (or the international equivalent) and early-phase clinical trials that test promising pharmacological interventions and devices for Alzheimer’s disease (AD) and related dementias.
Budget: Up to $5,000,000.
Duration: Not indicated.
Fill out the form below to receive more information: